£73.95

It has never been this cheap. We have no record of a lower price.

£74 today · cheaper than every other day in the last 3 months

Springer Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 56 days · 56 data points (no recent data)

Historical
Generating forecast…
£73.95 £70.25 £71.73 £73.21 £74.69 £76.17 £77.65 22 July 2026 04 August 2026 18 August 2026 01 September 2026 15 September 2026
View at Amazon ↗

9789811575853

Price data last checked 35 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 56 days • 1 price levels

Days at Price
56 days 0 14 28 42 56 £74 Days at Price

Price Analysis

Most common price: £74 (56 days, 100.0%)

Price range: £74 - £74

Price levels: 1 different prices over 56 days

Description

This book explores potential cellular drug targets for cancer therapy. The first couple of chapters describe conventional treatment (radiotherapy, chemotherapy, and immunotherapy) & detection (biosensors) strategies for cancer. In contrast, the subsequent chapters address the role of cyclin-dependent kinases and cell cycle regulatory proteins in the growth of cancer cells and their potential as target for cancer treatment. The book then discusses the regulation of various pro-apoptotic and anti-apoptotic proteins via chemotherapeutic drugs. In addition, it examines the molecular mechanisms that are critical for mediating autophagic cell death in cancer cells. It subsequently reviews the role of reactive oxygen (ROS) species during carcinogenesis and during chemotherapy, and the potential of anti-inflammatory routes for the development of new therapeutic modulators. Lastly, it describes therapeutic strategies that target the tumor microenvironment and various angiogenic pathways forthe treatment of cancer and to develop personalized medicine. Given its scope, the book is valuable resource for oncologists, cancer researchers, clinicians, and pharmaceutical industry personnel.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
99% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 08 Aug 2026
Cell Signaling & Molecular Targets in Cancer
89% match

Cell Signaling & Molecular Targets in Cancer

Springer

£109.62 20 Oct 2026
Cell Signaling & Molecular Targets in Cancer
88% match

Cell Signaling & Molecular Targets in Cancer

Springer

£43.99 04 Aug 2026
Trends in Stem Cell Proliferation and Cancer Research
88% match

Trends in Stem Cell Proliferation and Cancer Research

Springer

£174.99 14 Sep 2026
Molecular Therapies of Cancer
87% match

Molecular Therapies of Cancer

Springer

£108.35 31 Aug 2026
Pharmaceutical Perspectives of Cancer Therapeutics
87% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 08 Aug 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
86% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£76.42 05 Aug 2026
Nutraceuticals and Cancer
86% match

Nutraceuticals and Cancer

Springer

£113.76 05 Aug 2026
Receptor Tyrosine Kinases in Cancer (Cancer Drug Discovery and Development)
86% match

Receptor Tyrosine Kinases in Cancer (Cancer Drug Discovery and Development)

Springer

£108.01 31 Aug 2026
Targeting Autophagy in Cancer Therapy (Current Cancer Research)
86% match

Targeting Autophagy in Cancer Therapy (Current Cancer Research)

Springer

£74.66 16 Sep 2026
Bioactive Natural Products for the Management of Cancer: from Bench to Bedside
86% match

Bioactive Natural Products for the Management of Cancer: from Bench to Bedside

Springer

£73.77 16 Sep 2026
Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology
86% match

Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology

Springer

£113.03 15 Oct 2026
Cancer Drug Discovery: Science and History
86% match

Cancer Drug Discovery: Science and History

Springer

£113.76 05 Aug 2026
Checkpoint Controls and Targets in Cancer Therapy (Cancer Drug Discovery and Development)
86% match

Checkpoint Controls and Targets in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£108.01 12 Aug 2026
Gene Regulation and Therapeutics for Cancer
86% match

Gene Regulation and Therapeutics for Cancer

CRC Press

£72.24 04 Aug 2026
Current Cancer Therapeutics
86% match

Current Cancer Therapeutics

Springer

£77.47 16 Oct 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
86% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.67 05 Aug 2026
Molecularly Targeted Therapy for Childhood Cancer
85% match

Molecularly Targeted Therapy for Childhood Cancer

Springer

£148.21 17 Aug 2026
Tumor Cell Metabolism: Pathways, Regulation and Biology
85% match

Tumor Cell Metabolism: Pathways, Regulation and Biology

Springer

£76.42 05 Aug 2026
Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach
85% match

Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach

Springer

£74.35 08 Aug 2026
Systems Biology in Cancer Research and Drug Discovery
85% match

Systems Biology in Cancer Research and Drug Discovery

Springer

£108.01 05 Aug 2026
Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology
85% match

Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology

Springer

£109.11 14 Sep 2026
Mechanisms of Drug Resistance in Cancer Therapy: 249 (Handbook of Experimental Pharmacology, 249)
85% match

Mechanisms of Drug Resistance in Cancer Therapy: 249 (Handbook of Experimental Pharmacology, 249)

Springer

£108.01 16 Sep 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
85% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£73.10 06 Aug 2026